Literature DB >> 17299753

Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.

Elisabeth Petrasch-Parwez1, Huu-Phuc Nguyen, Marlen Löbbecke-Schumacher, Hans-Werner Habbes, Stefan Wieczorek, Olaf Riess, Karl-Hermann Andres, Rolf Dermietzel, Stephan Von Hörsten.   

Abstract

Huntington disease (HD) is a progressive neurodegenerative disorder characterized by emotional, cognitive, and motor dysfunctions. Aggregation of huntingtin is a hallmark of HD and, therefore, a crucial parameter for the evaluation of HD animal models. We investigated here the regional, cellular, and subcellular distribution of N-terminal huntingtin aggregates and associated neuropathological changes in the forebrain of a rat transgenic for HD (tgHD). The tgHD rat brain showed enormously enlarged lateral ventricles and a similar atrophy of cortical and subcortical areas as known in HD patients. Huntingtin aggregates of varying size and forms were regionally identified in neuronal nuclei, cytoplasm, dendrites, dendritic spines, axons, and synaptic terminals, closely resembling the results described earlier for human HD brains and in established HD mouse models. Huntingtin aggregates in mitochondria support mitochondrial dysfunction as contributing to the disease pathogenesis. Dark cell degeneration was reminiscent of results in HD individuals and HD mouse models. Interestingly, huntingtin aggregates were especially well accumulated in two interacting limbic forebrain systems, the ventral striatopallidum and the extended amygdala, which may contribute to the early onset of emotional changes observed in the tgHD rat. In conclusion, the tgHD rat model reflects to a remarkable extent the cellular and subcellular neuropathological key features as observed in human HD and HD mouse brains and hints of changes in limbic forebrain systems, which may elucidate the emotional dysfunction in the tgHD rat and affective disturbances in HD patients. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299753     DOI: 10.1002/cne.21272

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  32 in total

1.  Key role of nuclear medicine in seeking biomarkers of Huntington's disease.

Authors:  Ferdinando Squitieri; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

2.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

3.  N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

Authors:  Adam L Orr; Shihua Li; Chuan-En Wang; He Li; Jianjun Wang; Juan Rong; Xingshun Xu; Pier Giorgio Mastroberardino; J Timothy Greenamyre; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

4.  Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.

Authors:  Janett Eckmann; Laura E Clemens; Schamim H Eckert; Stephanie Hagl; Libo Yu-Taeger; Thierry Bordet; Rebecca M Pruss; Walter E Muller; Kristina Leuner; Huu P Nguyen; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-03-18       Impact factor: 5.590

Review 5.  Mitochondrial matters of the brain: the role in Huntington's disease.

Authors:  C Turner; A H V Schapira
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

Review 6.  Mitochondrial dynamic changes in health and genetic diseases.

Authors:  Le Chen; Allison J Winger; Anne A Knowlton
Journal:  Mol Biol Rep       Date:  2014-11       Impact factor: 2.316

Review 7.  Metabolism in HD: still a relevant mechanism?

Authors:  Wenzhen Duan; Mali Jiang; Jing Jin
Journal:  Mov Disord       Date:  2014-08-13       Impact factor: 10.338

Review 8.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

9.  Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice.

Authors:  Silke Nuber; Thomas Franck; Hartwig Wolburg; Ulrike Schumann; Nicolas Casadei; Kristina Fischer; Carsten Calaminus; Bernd J Pichler; Sittinan Chanarat; Peter Teismann; Jörg B Schulz; Andreas R Luft; Jürgen Tomiuk; Johannes Wilbertz; Antje Bornemann; Rejko Krüger; Olaf Riess
Journal:  Neurogenetics       Date:  2010-02       Impact factor: 2.660

10.  Oxidative stress and plasma aminopeptidase activity in Huntington's disease.

Authors:  Raquel Duran; Francisco J Barrero; Blas Morales; Juan D Luna; Manuel Ramirez; Francisco Vives
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.